Takeda Patient Support Co-Pay Assistance Program: Cuvitru

Funded

About

The Takeda Patient Support Co-Pay Assistance Program: Cuvitru offers significant financial benefits to eligible patients using the drug product Cuvitru. This program is designed to reduce out-of-pocket expenses, potentially lowering co-pays to as little as $0, with an annual maximum co-pay assistance of $20,000. The Takeda Patient Support Co-Pay Assistance Program aims to support patients with primary immunodeficiency by providing financial relief and resource guidance.

Insurance requirements: Commercially insured

Enrollment Forms

Enrollment Form

Program Requirements

•Valid only for residents in the US and Puerto Rico

•Enrollment Required: Yes

•Coverage Required: No

•Needs Based: No

•Activation Required: No

Program Details

•Eligible patients may pay as little as $0 copay

•The maximum copay assistance annually is $20,000; if patient reaches the program maximum before the end of the period, Takeda will help patient identify programs and resources that may provide with additional assistance

•Takeda Patient Support CoPay Assistance Program covers outofpocket expenses related to treatment copays, such as deductibles, coinsurance, and certain infusion charges (if applicable), up to the program maximum

•For additional information contact the program at 18668611750, Monday through Friday, 8 AM to 8 PM ET

Enrollment Forms

Enrollment Form